Anti-Ctip2 antibody
Specifications
| Product Cat#: | AB-06-1193 |
| Product type: | Primary antibody |
| Antigen: | Ctip2 |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:1000); Immunohistochemistry (1:50-1:200); Flow Cytometry (1:50-1:100); Immunocytochemistry (1:50-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (JF09-90) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | ATL1 alpha antibody |
| ATL1 antibody | |
| ATL1 beta antibody | |
| ATL1 gamma antibody | |
| ATL1-delta antibody | |
| B cell CLL/lymphoma 11B/T cell receptor delta constant region fusion protein antibody | |
| B cell lymphoma/leukemia 11B antibody | |
| B-cell CLL/lymphoma 11B (zinc finger protein) antibody | |
| B-cell CLL/lymphoma 11B antibody | |
| B-cell lymphoma/leukemia 11B antibody | |
| BC11B_HUMAN antibody | |
| BCL-11B antibody | |
| Bcl11b antibody | |
| BCL11B/TRDC fusion antibody | |
| COUP TF interacting protein 2 antibody | |
| COUP-TF interacting protein 2 antibody | |
| COUP-TF-interacting protein 2 antibody | |
| Ctip 2 antibody | |
| CTIP-2 antibody | |
| CTIP2 antibody | |
| hRIT1 alpha antibody | |
| hRit1 antibody | |
| Radiation induced tumor suppressor gene 1 antibody | |
| Radiation induced tumor suppressor gene 1 protein antibody | |
| Radiation-induced tumor suppressor gene 1 protein antibody | |
| Rit 1 antibody | |
| Rit1 antibody | |
| zinc finger protein hRit1 alpha antibody |
Show More
Target information
Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus (PubMed:27959755). Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4+ T-lymphocytes (PubMed:16809611). Tumor-suppressor that represses transcription through direct, TFCOUP2-independent binding to a GC-rich response element (By similarity). May also function in the P53-signaling pathway (By similarity).
Provider
Erpantech Laboratory